Impact of bridging therapy on efficacy of CD19 CAR T cell therapy in diffuse-large B cell lymphoma: Histology and the choice of drug matter
Julia Katharina Scholz, Evgenii Shumilov, Viktoria Blumenberg, Jonas Wißkirchen et autres
0 citationsBlood
Philipp Nakov
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
9Publications signalées
9Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchHematopoietic Stem Cell TransplantationMonoclonal and Polyclonal Antibodies ResearchCancer Immunotherapy and Biomarkers
Publications récentes
Prognostic impact of specific IGHV rearrangements in younger untreated Mantle Cell Lymphoma patients is independent of p53 alterations and may be modified by ibrutinib-based regimens: Insights from the TRIANGLE trial within the MULTIPLY project
Simone Ragaini, Katja Gutmair, Riccardo Moia, Mouhamad Khouja et autres
1 citationBlood
ctDNA dynamics demonstrates rapid treatment response to tafasitamab + R-CHOP +/− lenalidomide and predicts outcome in diffuse large B-cell lymphoma: results from the phase 1b First-MIND study
Mouhamad Khouja, Britta Kehden, Derek Blair, Christian Kuffer et autres
1 citationLeukemia
58 | DETECTION AND CLINICAL IMPACT OF SUBCLONAL TP53 MUTATIONS AND CHIP IN PATIENTS WITH MCL: RESULTS FROM THE EU‐MCL NETWORK TRIALS
S. Paasch, Mouhamad Khouja, Linmiao Jiang, Philipp Nakov et autres
0 citationsHematological Oncology
265 | IMPACT OF IGHV REPERTOIRE AFTER IBRUTINIB‐CONTAINING REGIMENS IN YOUNGER UNTREATED MCL PATIENTS: AN ANALYSIS OF THE TRIANGLE DATA EMBEDDED IN THE MULTIPLY PROJECT
Simone Ragaini, Riccardo Moia, Katja Gutmair, Mouhamad Khouja et autres
1 citationHematological Oncology
327 | LONG‐TERM OUTCOME OF PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA ACHIEVING CR USING BISPECIFIC ANTIBODIES
Evgenii Shumilov, Paolo Mazzeo, Joseph Kauer, Hristo Boyadzhiev et autres
0 citationsHematological Oncology
Immune checkpoint inhibitors therapy for solid organ malignancies after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Transplant Complications Working Party
Jan Brijs, C. Peczynski, William Boreland, Aurora Cuoghi et autres
1 citationBone Marrow Transplantation
Allogeneic Hematopoietic Stem Cell Transplantation From a CD36+ Donor in an Immunized Patient With Type I Hereditary CD36 Deficiency
Nicolas Spath, Philipp Nakov, Daniel Kownatzki-Danger, Dagmar Steppat et autres
0 citationsTransplantation
Venetoclax and Blinatumomab for Adult Patients with Relapsed/Refractory or MRD Positive Ph-Negative B-Precursor ALL: First Results of the GMALL-Bliven Trial
Lars Fransecky, Walter Fiedler, Christoph Röllig, Tim Sauer et autres
5 citationsBlood
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.